| Scientific Name | Trade Name |
Year of Approval* |
Mechanism of Action |
|---|---|---|---|
| Abatacept | Orencia | IV: 2010 SC: 2014 |
Selective T-cell co-stimulation modulator |
| Adalimumab | Humira | 2005 | TNF inhibitor |
| Etanercept | Enbrel | 2006 | TNF inhibitor |
| Golimumab | Symponi | 2015 | TNF inhibitor |
| Infliximab | Remicade | 2011 | TNF inhibitor |
| Remsima† | 2016 | – | |
| Rituximab | MabThera | 2008 | Targets CD20 on B cells |
| Tocilizumab | Actemra | IV: 2014 SC: 2017 |
IL-6 receptor antagonist |
| *Provided by the respective manufacturer. †Biosimilar IL, interleukin; IV, intravenous; SC, subcutaneous; TNF, tumor necrosis factor. |
|||